2 studies found for:    16873669 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting "MIRO" Molecularly Oriented Immuno-radio-therapy
Conditions: Follicular Lymphoma, Grade 1;   Follicular Lymphoma, Grade 2
Intervention: Drug: OFATUMUMAB
2 Active, not recruiting Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: rituximab;   Drug: CHOP regimen;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate

Indicates status has not been verified in more than two years